David Laskow- Pooley has joined TestAVec to accelerate the commercialisation of the science developed by Professor Themis.

As well as being a being a semi executive director of Testavec, Laskow- Pooley also holds non-executive director roles in both public and private companies.

 

Historically he has worked for companies as varied as Life Technologies, now part of Thermo Fisher Scientific and Amersham Pharmacia Biotech, now part of Cytivia, in addition to pharmaceutical companies, GSK, Abbive, and OSI Pharmaceuticals. He was on the Council of Oxford Brookes University and founded an independent company specialising in the spin-out and building of entities, principally in technologies resulting from academic research. He has been successful in the creation and development of several companies in small biotech, life science and devices, from early stage to full commercialisation.